efegatran has been researched along with Carotid Artery Thrombosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heran, CL; Michel, IM; Ogletree, ML; Schumacher, WA; Seiler, SM; Steinbacher, TE | 1 |
Deinum, J; Elg, M; Gustafsson, D | 1 |
2 other study(ies) available for efegatran and Carotid Artery Thrombosis
Article | Year |
---|---|
Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Binding Sites; Bleeding Time; Carotid Artery Thrombosis; Disease Models, Animal; Dose-Response Relationship, Drug; Heparin; Male; Mesenteric Arteries; Molecular Sequence Data; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombin; Thrombophlebitis | 1993 |
The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Arginine; Azetidines; Benzylamines; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Fibrinolytic Agents; Glycine; Hemodynamics; Heparin; Hirudin Therapy; Hirudins; Kinetics; Male; Oligopeptides; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfonamides; Thrombin; Thrombin Time | 1997 |